Objective: Selective serotonin reuptake inhibitors are commonly used for the treatment of
pregnancy-related and postnatal depression. However, only a few studies have evaluated …

Background This article presents an overview of the excretion of the SSRIs citalopram,
paroxetine, fluoxetine, fluvoxamine and sertraline in breast milk. Material and methods …

Mood and anxiety disorders are common in women during their childbearing years. The
prevalence of depression has been reported to be between 10% and 16% during …

The physiological changes of pregnancy can affect the pharmacokinetics of a drug, thereby
affecting its dose requirements. Because pharmacokinetic (PK) studies in pregnant women …

Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression
during pregnancy and the postpartum period. These drugs are capable of crossing the …

Selective serotonin reuptake inhibitors (SSRIs) have become the agents of first choice in the
treatment of depression because of their safe side effect profile. This paper reviews the …

The use of antidepressants during pregnancy has undergone considerable scrutiny with
respect to safety issues, though limited data with respect to dose management and symptom …

Objective The postnatal period represents a critical phase for mothers because of
physiological hormonal changes, the increase of emotional reactions and a greater …

The selective serotonin reuptake Inhibitor (SSRI) type of antidepressants which include
fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), and fluvoxamine (Luvox), are …

Depression is common in women of childbearing age. Whereas non-pharmacological
interventions are recommended as first line interventions, pharmacological treatment may …